KZA 5.60% 66.0¢ kazia therapeutics limited

Novogen top 20 - Another interesting Find

  1. 3,567 Posts.
    Looking through the recent top 20 announcement I noticed that Mr Edmund Hugh Conyber Kelly was a new top 20 shareholder with a 256400 share stake. Not sure if there is any relation to Graham Kelly (info below).

    Dr Graham E Kelly:
    Executive Director since T994, Dr Kelly is founder and was the first Managing Director of Novogen limited. Dr Kelly was
    Chairman of the Novogen Gloup until the 31 December 2000 a position he had held since March 1997, he is also
    Chairman of subsidiary company Marshall Edwards, Inc. He has spent nearly 30 years in medical research involving drug
    development, immunology, surgery and cancer. Dr Kelly was Seniof Research Fellow in Experimental Surgery in the Faculty
    of Medicine at the University of Sydney. He developed the B-l, 3-Giucan and Isoflavonoid compounds now o m e d by the
    Novogen Group.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Last
66.0¢
Change
0.035(5.60%)
Mkt cap ! $88.89M
Open High Low Value Volume
62.0¢ 66.5¢ 62.0¢ $20.15K 31.23K

Buyers (Bids)

No. Vol. Price($)
2 50574 65.0¢
 

Sellers (Offers)

Price($) Vol. No.
67.0¢ 13978 2
View Market Depth
Last trade - 13.52pm 24/06/2022 (20 minute delay) ?
(live)
Last
66.0¢
  Change
0.035 ( 5.60 %)
Open High Low Volume
64.5¢ 66.0¢ 64.5¢ 2006
Last updated 12.09pm 24/06/2022 (live) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.